Brentuximab vedotin in combination with or without donor lymphocyte infusion for patients with Hodgkin lymphoma after allogeneic stem cell transplantation
暂无分享,去创建一个
A. Nagler | M. Mohty | R. Yerushalmi | A. Shimoni | J. Gauthier | A. Spyridonidis | P. Tsirigotis | G. Goldstein | A. Avigdor | J. Apostolidis | N. Shem-Tov | I. Danylesko | K. Gkirkas | M. Stamouli